Long-Stay Pet Program helps pets find forever home
The BISSELL Pet Foundation launched its new Long-Stay Pet program.
Dogs and cats that have been waiting adoption for more than 30 days will get added to BISSELL's online platform.
Other shelters can see which animals are available on the platform and ask to have them transferred to their facility.
The shelter manager at the Humane Society, Amberly Ondria, says sometimes, just showing the pets to a new audience is all it takes for them to find their forever home.
'See if they would like to trade dogs. Or even, if they don't want to trade, maybe they have an adopter who's looking for a border collie, and they don't have one in their area. But a humane society in Rochester may have it. They can pull that dog from that shelter, bring it to their facility, and pursue an adoption with somebody who may be looking for that animal,' said Ondria.
Ondria says all across the country, shelters are struggling with increased capacity.
The Humane Society says from 2023 to 2024, dog adoptions have declined by 1%.
Community members are encouraged to visit their local shelters regularly, as new pets will continually be transferred in.
ACA launches rebrand will help of former client
Riley backs bill that aims to lower energy costs
Molinaro nominated to lead Federal Transit Administration
Truth Pharm continues to combat opioid crisis with new initiatives
Long-Stay Pet Program helps pets find forever home
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
a day ago
- Boston Globe
Madbury, N.H. woman killed husband, 2 children, and herself in murder-suicide, autopsies show
Two of the Long's children, son Parker, 8, and their daughter Ryan, 6, each died from a single gunshot wound to the head, Formella's statement said. Immediately afterward, Long turned the gun on herself and shot herself once in the head, Formella said. A toddler was found unharmed at the home on Moharimet Drive late Monday night when the bodies were discovered, officials said. Advertisement Autopsies concluded that the father's and two children's manners of deaths were homicides, and Emily Long's was suicide, the statement said. 'While investigators are becoming aware of various concerns/issues ongoing in the household at the time of the event in question, people should avoid speculating that this event was caused by a single reason or stressor,' Formella's joint statement said. Ryan Long was a school psychologist at Oyster River Middle School in Durham. He was recently diagnosed with an aggressive form of brain cancer, a cousin told the Globe Tuesday. She said his children knew he was receiving treatment at Massachusetts General Hospital and the family seemed to have a great deal of support. 'This is why we're just all so in shock. We have a lot of family, a lot of friends, that would do anything for them because, you know, they would do it, too.' Relatives will be coming together in New Hampshire to grieve, the cousin said. Advertisement Ryan Logan was also an adjunct professor at Plymouth State University, according to his LinkedIn profile and published reports. Emily Long worked for Wing-Itz, a chicken wing restaurant with three locations in New Hampshire's Seacoast region, where she was listed on the restaurant's website as the director of operations. She studied hospitality management at UNH, according to a university spokesperson. A 911 call was placed from the home around 8:20 p.m. Monday, reporting 'several people were deceased,' officials said. Formella's office reminded residents who are in crisis should call, text, or chat with someone at the Suicide and Crisis Lifeline at 9-8-8, or contact the Crisis Text Line by texting TALK 741741. Tonya Alanez can be reached at
Politico
13-08-2025
- Politico
Long Covid's lingering financial side effects
LONG COVID'S TOLL — More than five years after the Covid-19 pandemic first ravaged the nation, many Americans are still dealing with the social and economic fallout of having contracted the disease. People with long Covid — those who have new or persistent symptoms lasting three months past infection — have experienced worse financial and employment outcomes, lasting up to three years after their initial infection, compared with people who haven't had the disease, according to a study published Tuesday in JAMA Network Open from researchers at Rush University Medical Center, Yale School of Medicine, Johns Hopkins University School of Medicine and other research institutions. Long Covid patients reported worse work impairment, missed work and financial distress compared with those who never had Long Covid, the study found. Vaccination against Covid was associated with improved work and economic outcomes. Not just physical: 'While much of the focus in Long COVID research has been on the medical impact, we must also consider the sustained financial burden faced by those whose symptoms persist,' lead author Michael Gottlieb, an emergency medicine doctor and vice chair of research at Rush, said in a statement. Addressing the financial burden of long Covid might 'require policy interventions, such as expanded disability benefits or workplace accommodations to help combat the work and financial impact of this condition,' the authors wrote. The researchers analyzed self-reported data from more than 3,600 participants in the Innovative Support for Patients with SARS-CoV-2 Infections Registry, a CDC-funded initiative aimed at better understanding Covid's long-term effects. Why it matters: About 6 percent of U.S. adults suffer from some form of long Covid, according to CDC estimates. The National Institutes of Health believes that as many as 23 million people have the illness, which can range in severity from mild to debilitating. The symptoms, which can include fatigue, headaches and brain fog, can be life-disrupting for many patients. Some treatments, like Paxlovid, have shown promise in reducing symptoms, but being diagnosed and finding suitable treatment can be difficult because of the disease's wide range of symptoms that often overlap with other conditions. HHS recently shut down its long Covid office, a casualty of the Trump administration's sweeping reorganization of the agency. At the time the closure was announced, an HHS employee who worked on long Covid and who was granted anonymity to share details of the move told POLITICO that abandoning work that could have cured the disease means the country's health care system will have to provide years, if not decades, of costly care for tens of millions of chronically ill people. In March, the Trump administration also canceled dozens of grants for long Covid projects, but some funding was restored after advocates fought back. WELCOME TO WEDNESDAY PULSE. I'm still reeling from Taylor Swift announcing her new album. Send your Swiftie theories, scoops and feedback to khooper@ and sgardner@ and follow along @kelhoops and @sophie_gardnerj. At the Agencies LOOMER'S LATEST PREY — After successfully ousting several members of Trump's administration for alleged insufficient loyalty, far-right activist and MAGA influencer Laura Loomer tells our colleagues at Playbook that she has her next target: Stefanie Spear, the principal deputy chief of staff and senior counselor to HHS Secretary Robert F. Kennedy Jr. The reason why, in part: 'I think that there's a clear intention by Stefanie Spear to utilize her position to try to lay the groundwork for a 2028 RFK presidential run,' Loomer alleges. Asked for comment by Playbook, a senior HHS official did not deny that Kennedy is weighing a presidential bid. Read the full story in this morning's Playbook. CDC LATEST — CDC officials held a tense all-hands meeting Tuesday in the aftermath of last week's shooting at the agency's Atlanta headquarters, Sophie reports with POLITICO's Amanda Friedman and Lauren Gardner. The meeting came as law enforcement officials revealed early Tuesday additional information about the nature of the shooting: The man who opened fire at the agency on Friday died of a self-inflicted gunshot wound and was motivated by his distrust of Covid-19 vaccines. Agency update: At the CDC's all-hands meeting, Director Susan Monarez thanked employees for their work and acknowledged that 'misinformation can be dangerous,' according to a live transcript obtained by POLITICO. 'In moments like this, we must meet the challenges with rational, evidence-based discourse spoken with compassion and understanding,' she said. 'That is how we will lead.' CDC employees were closely watching Monarez at the meeting to see how she would respond to the shooting and the news that the suspected shooter had expressed distrust of the Covid vaccine. Two CDC employees, granted anonymity to speak candidly, told POLITICO that Monarez's speech was not what they'd hoped. '[Twenty minutes] of reading off a teleprompter,' one of the employees said in a text, adding that Monarez's remarks prompted an 'overwhelmingly negative response from folks in my immediate orbit.' Another agency employee said the meeting was in stark contrast to a separate meeting held for the CDC's National Center for Immunization and Respiratory Diseases staff on Saturday, where employees could ask Monarez questions. What's next: HHS spokesperson Andrew Nixon said that staff would have 'continued opportunities' to voice their perspectives to CDC leadership in the days ahead. 'Friday's shooting was a traumatic event for the agency, and leadership is working to provide continued updates along with resources for healing and recovery,' Nixon said in a statement. DOGE SAVINGS — The Trump administration has drastically exaggerated how much money it has saved through DOGE-related cuts to federal contracts, including at health agencies, according to an analysis of public data and federal spending records from POLITICO's Jessie Blaeser. Through July, DOGE said it had saved taxpayers $52.8 billion by canceling contracts, but of the $32.7 billion in actual claimed contract savings that POLITICO could verify, DOGE's savings over that period were closer to $1.4 billion. Despite the administration's claims, none of that $1.4 billion will lower the federal deficit unless Congress steps in. Instead, the money has been returned to agencies mandated by law to spend it. The health claims: Under the VA, DOGE's wall of receipts reported savings of $932 million from contracts canceled through June, including awards for a cancer registry, suicide-prevention services and other health care support. Federal records show the VA recovered just $132 million from the awards, or less than 15 percent of what DOGE claimed, and that the VA reinstated the contract for suicide-prevention support. One of DOGE's largest savings claims is from a canceled contract for a shelter in Pecos, Texas, to house unaccompanied migrant children. In a post on social media platform X in February, DOGE said HHS 'paid ~$18M/month' to keep the now-empty center open. Canceling the agreement, it said, would translate to more than $215 million in annual savings for taxpayers. By the time the contract was added to the DOGE termination list, that savings claim skyrocketed to $2.9 billion. But HHS and its Office of Refugee Resettlement were not on track to spend anywhere close to the contract's $3.3 billion ceiling. WHAT WE'RE READING POLITICO's Tyler Katzenberger reports on a federal judge blocking the Trump administration from using Medicaid beneficiaries' personal data for immigration enforcement purposes. Bloomberg Law's Celine Castronuovo reports on Texas' attorney general accusing Eli Lilly of unlawfully pushing providers to prescribe its blockbuster obesity drugs and other treatments to receive Medicaid payments.
Medscape
06-08-2025
- Medscape
Port Delivery System Outperforms Injections for DME
Implantation in the eye of the port delivery system loaded with a bolus of the antivascular endothelial growth factor ranibizumab was associated with similar improvements in visual acuity after 2 years as intravitreal injections with ranibizumab in people with diabetic macular edema, results of a subset analysis of a phase 3 trial have shown. However, anatomical improvements were more profound in the eyes treated with the port system, and they did not progress onto proliferative diabetic retinopathy or have any reports of endophthalmitis, whereas a portion of the injected eyes did, Jordan Graff, MD, reported at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California. Jordan Graff, MD 'The port delivery system provides excellent pharmacokinetics and disease control with vision comparable to monthly injection and a reduction in edema that was superior to an idealized standard-of-care injection model,' Graff, a vitreoretinal surgeon at Barnet Dulaney Perkins Eye Center in Phoenix, told Medscape Medical News . 'When we looked at complicating factors, we found that the safety outcome signals were essentially equal,' he added. Study Results The subset analysis included 241 patients with diabetic macular edema in both eyes from the phase 3 Pagoda trial. In this subset, the participants had the port system implanted in the eye with worse visual acuity and central subfield thickness, an anatomical measure of edema in the eye based on optical coherence tomography. The other eye, referred to as the fellow eye, was treated with intravitreal injections of ranibizumab on the basis of the clinician's discretion. The port system is an implant about the size of a grain of rice, which is inserted into the eye. It consists of a reservoir designed to be filled with 0.2 mL of 100 mg/mL ranibizumab by injection. The implant releases the drug into the eye over 6 months for diabetic macular edema and neovascular age-related macular edema, and over 9 months for diabetic retinopathy. Participants in the Pagoda trial received the implant after 4 monthly loading doses of ranibizumab. The FDA approved the implant in February 2022. In the subset analysis, the eyes with the port system received on average nine treatments over 2 years, including the four loading doses, and one initial and four refills. The fellow eyes received 12 injections, Graff reported in presenting the results. Visual acuity improvements were similar in both groups, Graff said. The eyes with the port implants improved from 64.2 ETRDS letters at entry to 74.3 at 2 years, about 20/50 to 20/32 in terms of Snellen visual acuity; the fellow eyes from 69.5 to 75.2 letters (20/40 to 20/32 Snellen). 'What was a surprise and really encouraging to find was that the study eyes with the port, which were the worse eyes, ultimately did better than the eyes that were given ad-lib access to repeated injections in an idealized standard-of-care environment,' Graff told Medscape Medical News. Central subfield thickness in the port eyes improved from 497.8 microns upon enrollment to 274.5 microns at 2 years, Graff said. For the fellow eyes, the improvement was less dramatic: from 399.1 to 331 microns. The lower the measure, the less extensive the macular edema. The subset analysis also looked at the proportion of eyes in each group that had more than a two-step improvement in Diabetic Retinopathy Severity Score, a measure of disease activity. Slightly more than half — 50.2% — of the port eyes experienced such an improvement at 2 years vs 31.7% of the fellow eyes. Graff added the rates of endophthalmitis were similar in both groups: one patient in each. None of the eyes with the port system had an implant dislocation. The rates of vitreous hemorrhage were 10% in the port eyes and 7.5% in the fellow eyes. No eyes in the port group progressed to proliferative diabetic retinopathy, whereas seven of the injection eyes did, he said. After completing a patient preference questionnaire, 77.5% of participants said they preferred the port to standard injections, Graff said. 'Those points give us the chance to pause as retinal surgeons and think, 'If I'm not already implementing this in my diabetic patients, I need to give this another look,'' Graff told Medscape Medical News . 'We are seeing the collective learnings of using the port delivery platform starting to take effect.' Study Strengths, Limitations 'The findings reveal that in patients with bilateral diabetic macular edema that the port delivery system actually works quite well,' Raj Maturi, MD, a vitreoretinal surgeon at Midwest Eye Institute and Retina Partners Midwest in Carmel, Indiana, told Medscape Medical News . 'The visual acuity gains in this eye compared to the fellow eye that was treated are greater. It's possible this happened because they started off with worse vision to begin with, but they improved quite a bit nonetheless.' Raj Maturi, MD Maturi noted that the 12 injections the fellow eyes received over the 2-year study was 'a little low,' as the label indication recommends monthly injections. Knowing the protocol investigators followed to administer injections to the fellow eye would help to better understand those outcomes, he said. 'An ultimate strength' of the analysis was to use both routes of administration in each patient, Maturi said. 'It takes care of all the variables, as it is two eyes of the same subject, so all the systemic variables have essentially been eliminated,' he said. The fact that the fellow eyes did not improve as much as the port eyes may indicate that the chronic drug exposure the implant provides may be better than the intimate exposure of injections. 'This study helps me promote port delivery system treatment for diabetic retinopathy,' Maturi said. The Pagoda trial was funded by Genentech. Graff reported having relationships with Regeneron Pharmaceuticals and Genentech. Maturi reported having relationships with AbbVie.
